NEEDS ASSESSMENT QUESTIONNAIRE
The Irritable Bowel Syndrome (IBS)
There is a need for further education in the following areas:
4 = Strongly Agree
3 = Agree
2 = Somewhat Disagree
1 = Disagree
4
3
2
1
The physiology of the enteric nervous system, and the pathophysiological factors that lead to the development of IBS
4
3
2
1
The possible role of genetic factors, and enteric pathogens in IBS
4
3
2
1
The diagnosis of IBS, based on symptoms, laboratory tests, and its differentiation from chronic constipation and other functional gastrointestinal disorders
4
3
2
1
An evidence-based analysis of the efficacy and safety of drugs used for the treatment of IBS, including IBS with constipation, as a dominate symptom, and IBS with diarrhea as a dominate symptom
Hepatitis B (HBV)
There is a need for further education in the following areas:
4 = Strongly Agree
3 = Agree
2 = Somewhat Disagree
1 = Disagree
4
3
2
1
The burden of illness, natural history and complications of HBV
4
3
2
1
The optimal utilization of laboratory tests to diagnose HBV, and to guide management decisions
4
3
2
1
An evidence-based review of currently available drugs used in the treatment of HBV, including efficacy, safety, viral resistance, and protocols for therapy
4
3
2
1
Issues related to HBV drug resistant mutants, and management of treated patients who have developed HBV drug resistance.
4
3
2
1
The management of special populations infected with HBV
4
3
2
1
The mechanism of action and efficacy of drugs in clinical trials for the treatment of HBV
Inflammatory Bowel Diseases (IBD)
There is a need for further education in the following areas:
4 = Strongly Agree
3 = Agree
2 = Somewhat Disagree
1 = Disagree
4
3
2
1
The pathophysiology of IBD including Crohn's Disease(CD), and Ulcerative Colitis (UC)
4
3
2
1
The efficacy and safety of the various mesalamine drugs used in the treatment of UC
4
3
2
1
Issues related to compliance with therapy in UC patients
4
3
2
1
Surveillance for colon cancer in patients with UC or Crohn's colitis
4
3
2
1
Chemoprevention of colon cancer in IBD patients
4
3
2
1
The role of "biological" agents, (e.g. anti-TNF-alpha), in the management of IBD, including mechanism of action, initiation of therapy, long-term maintenance therapy, and comparative efficacy and safety of currently available drugs.
Acid-Peptic Disorders
There is a need for further education in the following areas:
4 = Strongly Agree
3 = Agree
2 = Somewhat Disagree
1 = Disagree
4
3
2
1
Issues related to Barrett's Esophagus, including pathobiology, endoscopic surveillance, advances in endoscopic mucosal ablation
4
3
2
1
The effects of NSAIDs on the GI tract, including risk factors, prophylaxis and management of GI bleeding.
4
3
2
1
The diagnosis and management of Eosinophilic Esophagitis
4
3
2
1
Update on the pharmacology of Proton Pump Inhibitors (PPIs), and their optimal utilization in a variety of acid-related esophageal disorders
Metabolic Diseases
There is a need for further education in the following areas:
4 = Strongly Agree
3 = Agree
2 = Somewhat Disagree
1 = Disagree
4
3
2
1
The diagnosis and management of the Metabolic Syndrome
4
3
2
1
Advances in the management of Type 2 diabetes
4
3
2
1
Recognition and treatment of dyslipidemia
4
3
2
1
The relationship of Fatty Liver, (Non-Alcoholic Fatty Liver Disease-NAFLD to obesity, diabetes and the Metabolic Syndrome
4
3
2
1
Diagnosis and management of NAFLD, and Non-alcoholic steatohepatitis, NASH
Produced by Digestive Diseases Education Company, Chicago, Illinois.
Copyright © 2008 by Digestive Diseases Education Company
